Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepa M Gopal

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
American Heart Journal|June 17, 2018
First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalizationAdriana Luk, John D Groarke, Akshay S Desai, et al.
Genome Research|April 16, 2024
A systematic review on the biochemical threshold of mitochondrial genetic variantsKaran K Smith, Jesse D Moreira, Callum R Wilson, et al.
Arthritis Care & Research|June 4, 2021
Prognostic Value of Cardiac Axis Deviation in Systemic Sclerosis-Related Pulmonary HypertensionJustin K Lui, Ruchika A Sangani, Clara A Chen, et al.
Obesity (Silver Spring, Md.)|July 25, 2017
Preclinical Alterations in Myocardial Microstructure in People with Metabolic SyndromeJennifer E Ho, Youssef Rahban, Harpaul Sandhu, et al.
Journal of the American Heart Association|January 15, 2013
Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failureDeepa M Gopal, Maya Kommineni, Nir Ayalon, et al.
Cardiovascular Drugs and Therapy|January 20, 2023
Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis‑Related Pulmonary HypertensionJustin K Lui, Ruchika A Sangani, Kari R Gillmeyer, et al.
Cardiovascular Drugs and Therapy|January 6, 2023
Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary HypertensionJustin K Lui, Ruchika A Sangani, Kari R Gillmeyer, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 29, 2025
Exercise cardiovascular magnetic resonance myocardial dynamic index: A non-invasive imaging marker associated with cardiac dyspneaFahime Ghanbari, Jennifer Rodriguez, Manuel A Morales, et al.
Lung|November 13, 2023
A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary HypertensionJustin K Lui, Kari R Gillmeyer, Ruchika A Sangani, et al.
Circulation. Heart Failure|July 16, 2015
Preclinical Systolic and Diastolic Dysfunctions in Metabolically Healthy and Unhealthy Obese IndividualsYi-Chih Wang, Chang-Seng Liang, Deepa M Gopal, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
American Heart Journal|June 17, 2018
First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalizationAdriana Luk, John D Groarke, Akshay S Desai, et al.
Genome Research|April 16, 2024
A systematic review on the biochemical threshold of mitochondrial genetic variantsKaran K Smith, Jesse D Moreira, Callum R Wilson, et al.
Arthritis Care & Research|June 4, 2021
Prognostic Value of Cardiac Axis Deviation in Systemic Sclerosis-Related Pulmonary HypertensionJustin K Lui, Ruchika A Sangani, Clara A Chen, et al.
Obesity (Silver Spring, Md.)|July 25, 2017
Preclinical Alterations in Myocardial Microstructure in People with Metabolic SyndromeJennifer E Ho, Youssef Rahban, Harpaul Sandhu, et al.
Journal of the American Heart Association|January 15, 2013
Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failureDeepa M Gopal, Maya Kommineni, Nir Ayalon, et al.
Cardiovascular Drugs and Therapy|January 20, 2023
Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis‑Related Pulmonary HypertensionJustin K Lui, Ruchika A Sangani, Kari R Gillmeyer, et al.
Cardiovascular Drugs and Therapy|January 6, 2023
Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary HypertensionJustin K Lui, Ruchika A Sangani, Kari R Gillmeyer, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 29, 2025
Exercise cardiovascular magnetic resonance myocardial dynamic index: A non-invasive imaging marker associated with cardiac dyspneaFahime Ghanbari, Jennifer Rodriguez, Manuel A Morales, et al.
Lung|November 13, 2023
A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary HypertensionJustin K Lui, Kari R Gillmeyer, Ruchika A Sangani, et al.
Circulation. Heart Failure|July 16, 2015
Preclinical Systolic and Diastolic Dysfunctions in Metabolically Healthy and Unhealthy Obese IndividualsYi-Chih Wang, Chang-Seng Liang, Deepa M Gopal, et al.
Pageof 6